참고문헌
- Abbasi MM, Jahanban-Esfahlan R, Monfaredan A, et al (2014a). Oral and IV dosages of doxorubicin-methotrexate loadednanoparticles inhibit progression of oral cancer by downregulation of matrix methaloproteinase 2 expression in vivo. Asian Pac J Cancer Prev, 15, 10705-11.
- Abbasi MM, Khiavi MM, Monfaredan A, et al (2014b). DOXMTX- NPs augment p53 mRNA expression in OSCC model in rat: effects of IV and oral routes. Asian Pac J Cancer Prev, 15, 8377-82. https://doi.org/10.7314/APJCP.2014.15.19.8377
- Abbasi MM, Monfaredan A, Hamishehkar H, et al (2014c). New formulated "DOX-MTX-loaded nanoparticles" downregulate HER2 gene expression and improve the clinical outcome in OSCCs model in rat: the effect of IV and oral modalities. Asian Pac J Cancer Prev, 15, 9355-60. https://doi.org/10.7314/APJCP.2014.15.21.9355
- Abbasi MM, Monfaredan A, Hamishehkar H, et al (2014d). Novel DOX-MTX nanoparticles improve oral SCC clinical outcome by down regulation of lymph dissemination factor VEGF-C expression in vivo: oral and IV modalities. Asian Pac J Cancer Prev, 15, 6227-32. https://doi.org/10.7314/APJCP.2014.15.15.6227
- Abusail M, Dirweesh AM, Salih RA, et al (2013). Expression of EGFR and p53 in head and neck tumors among sudanese patients. Asian Pac J Cancer Prev, 14, 6415-8 https://doi.org/10.7314/APJCP.2013.14.11.6415
- Ahmadi A, Habibi G, Farrokhnia M (2010a). Anticancer effects of HESA-A: An herbal marine compound. Chin J Integr Med, 16, 366-7. https://doi.org/10.1007/s11655-010-0517-x
- Ahmadi A, Mohagheghi M, Karimi M, et al (2009). Anticancer effects of HESA-A in patients with metastatic colon cancer. Integr. Cancer Ther, 8, 71-4. https://doi.org/10.1177/1534735408327995
- Ahmadi A, Mohagheghi M, Karimi M, et al (2010b). Therapeutic effects of HESA-A in patients with end-stage metastatic cancers. Integr. Cancer Ther, 9, 32-5. https://doi.org/10.1177/1534735409357934
- Ahmadi A, Mohagheghi MA, Fazeli MS, et al (2005). HESA-A: new treatment for breast cancer and choroidal metastasis. Med Sci Monit, 11, 300-3.
- Jahanban Esfahlan R, Zarghami N, Jahanban Esfahlan A, et al (2011a). The possible impact of obesity on androgen, progesterone and estrogen receptors (ERa and ERb) gene expression in breast cancer patients. breast cancer (Auckl), 227-37.
- Jahanban Esfahlan R, Zarghami N, Rahmati-Yamchi M, et al (2011b). Quantification of steroid receptors gene expression in breast cancer patients: possible correlation with serum level of adipocytokines. J Cancer Therapy, 2, 659-65. https://doi.org/10.4236/jct.2011.25088
- Jahanban Esfahlan R, Zarghami N, Valiyari S, et al (2012). Adiponectin can affect ER signaling in obese breast cancer patients. J Cancer Therapy, 3, 115-21 https://doi.org/10.4236/jct.2012.31015
- Mehdipour M, Taghavi Zenouz A, Mesgari Abbasi M, et al (2013b). Evaluation of the effect of two systemic doses of HESA-A on prevention of induced tongue neoplasm in rats. J Dent Res Dent Clin Dent Prospects, 7, 218-24.
- Muhammmadnejad S, Zendehdel K, Mazaheri Z, et al (2014). Assessment of selective growth inhibitory effects of HESA-A on some human neoplastic cell lines. Breast Cancer: Basic and Clinical Res, 6.
- Valiyari S, Jahanban-Esfahlan R, Zare Shahneh F, et al (2013). Cytotoxic and apoptotic activity of Scrophularia oxysepala in MCF-7 human breast cancer cells. Toxicol Environmental Chem, 95, 1208-20. https://doi.org/10.1080/02772248.2013.854362
- Zwetyenga N, Majoufre-Lefebvre C, Siberchicot F, et al (2003). [Squamous-cell carcinoma of the tongue: treatment results and prognosis]. Rev Stomatol Chir Maxillofac, 104, 10-7.